HealthEquity upgraded by Raymond James with a new price target
$HQY
Business Services
Consumer Discretionary
Raymond James upgraded HealthEquity from Outperform to Strong Buy and set a new price target of $115.00 from $120.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/22/2025 | $105.00 → $112.00 | Outperform | RBC Capital Mkts |
| 3/25/2025 | $120.00 → $115.00 | Outperform → Strong Buy | Raymond James |
| 12/4/2024 | $126.00 | Outperform | Mizuho |
| 11/15/2024 | $108.00 | Neutral | Goldman |
| 4/4/2024 | $101.00 | Mkt Outperform | JMP Securities |
| 4/2/2024 | $86.00 → $108.00 | Overweight | JP Morgan |
| 1/3/2024 | $84.00 | Overweight | Barclays |
| 9/21/2023 | $79.00 → $87.00 | Neutral → Outperform | Robert W. Baird |
RBC Capital Mkts resumed coverage of HealthEquity with a rating of Outperform and set a new price target of $112.00 from $105.00 previously
Raymond James upgraded HealthEquity from Outperform to Strong Buy and set a new price target of $115.00 from $120.00 previously
Mizuho initiated coverage of HealthEquity with a rating of Outperform and set a new price target of $126.00
10-Q - HEALTHEQUITY, INC. (0001428336) (Filer)
8-K - HEALTHEQUITY, INC. (0001428336) (Filer)
DEFA14A - HEALTHEQUITY, INC. (0001428336) (Filer)
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)